Dr Robert Bernard Perch, MD | |
10817 Valley Forge Circle, King Of Prussia, PA 19406 | |
(610) 783-1817 | |
Not Available |
Full Name | Dr Robert Bernard Perch |
---|---|
Gender | Male |
Speciality | Urology |
Location | 10817 Valley Forge Circle, King Of Prussia, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649390451 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | MD025263L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert Bernard Perch, MD 10817 Valley Forge Circle, King Of Prussia, PA 19406 Ph: (610) 783-1817 | Dr Robert Bernard Perch, MD 10817 Valley Forge Circle, King Of Prussia, PA 19406 Ph: (610) 783-1817 |
News Archive
The Center for Strategic & International Studies (CSIS) "wanted to learn more about how women leaders in Africa are bringing new attention to women's health and empowerment in their own countries, and to bring those voices into the discussion about U.S. policy priorities for women's global health," so a small CSIS team traveled to Malawi and Zambia in December 2012, Janet Fleischman and Julia Nagel of CSIS write in the group's Smart Global Health blog.
A study by the Centers for Disease Control and Prevention concluded that adults younger than 65 were more likely than older Americans to skip medicines, or not take them as prescribed.
Results of a head-to-head comparison study led by Johns Hopkins researchers show that noninvasive CT scans of the heart's vessels are far better at spotting clogged arteries that can trigger a heart attack than the commonly prescribed exercise stress that most patients with chest pain undergo.
LaunchPad Medical, LLC announced today that it has entered into a definitive agreement to license Stryker Corporation's bone adhesive technology, which is based on a unique synthetic biomaterial. Under the terms of the agreement, LaunchPad has received an exclusive worldwide license from Stryker for this technology which is covered by four issued and three pending U.S. patents and includes data from multiple pre-clinical animal studies.
› Verified 1 days ago